FDA Approved: DEFERASIROX — Original Application (Teva Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Teva's Deferasirox as an original generic application, enabling broader access to this iron chelation therapy for patients with chronic iron overlo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Beta-thalassemia
• Myelodysplastic Syndrome
• Sickle Cell Disease
• Transfusional Iron Overload

Drugs mentioned

• Deferasirox (Deferasirox)

Snippet

ORIG AP for DEFERASIROX (DEFERASIROX)